|
Real-time Estimate
Cboe BZX
15:52:05 03/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 224.35 USD | +0.75% |
|
+0.91% | +27.00% |
| 12:37pm | Piper Sander Adjusts Biogen Price Target to $245 From $225, Maintains Overweight Rating | MT |
| 08-25 | Veeva Systems Secures Biogen, Regeneron Pharmaceuticals as New Vault CRM Clients | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.75% | +0.91% | +10.75% | +14.06% | +27.00% | +57.82% | -16.07% | -33.00% | -28.06% | 32.9B | |
| -1.41% | +4.07% | +10.72% | +35.81% | +8.91% | +49.10% | +2.15% | +23.70% | +111.04% | 85.08B | |
| -4.21% | +2.13% | +164.43% | +197.20% | +394.42% | +506.26% | +33.33% | -65.01% | - | 60.21B | |
| +0.95% | +1.77% | +42.61% | +89.61% | +1.65% | -15.77% | -34.78% | -42.16% | +67.25% | 59.71B | |
| -1.25% | -6.13% | +1.08% | +9.80% | -11.45% | -2.08% | +33.18% | +2.98% | - | 51.1B | |
| -0.36% | -0.95% | -0.72% | -12.74% | -7.88% | +8.81% | +168.97% | +124.19% | +197.03% | 48.73B | |
| -0.66% | +0.05% | +7.92% | +30.44% | +29.40% | +46.98% | +101.98% | +67.97% | +52.61% | 26.11B | |
| +0.79% | -6.56% | +18.34% | +30.12% | +34.56% | -2.56% | +192.31% | +58.58% | - | 22.6B | |
| +1.12% | -1.97% | +5.18% | +5.43% | +37.80% | +63.67% | +112.51% | +88.57% | +352.71% | 16.42B | |
| -0.83% | -4.17% | +25.79% | +8.70% | -13.67% | -16.10% | +786.97% | +452.38% | +6,858.80% | 15.3B | |
| -0.76% | -3.60% | -5.14% | +15.84% | -0.84% | +46.32% | +156.08% | +46.94% | - | 14.96B | |
| +0.12% | +2.89% | +11.98% | +22.91% | +13.04% | +13.90% | -25.96% | -20.92% | -29.72% | 12.96B | |
| -1.36% | +0.19% | -2.07% | -11.49% | +13.15% | +69.40% | +162.37% | +674.32% | +2,754.49% | 11B | |
| +0.19% | +3.70% | +18.59% | +22.82% | +50.35% | +146.79% | +198.75% | +532.89% | - | 10.93B | |
| -1.48% | -15.67% | +27.76% | +78.50% | +307.03% | +396.58% | +451.05% | +12.55% | - | 8.21B | |
| +0.72% | -1.04% | -1.09% | +10.93% | -7.01% | -16.53% | -21.62% | -52.44% | -48.34% | 6.87B | |
| -0.11% | -0.35% | +8.32% | +66.19% | +92.78% | +124.13% | +370.53% | +545.45% | - | 6.23B | |
| -2.07% | -2.38% | +1.27% | +26.57% | +2.25% | -10.02% | +64.58% | -14.28% | - | 6.16B | |
| -0.76% | -4.54% | +1.99% | -0.44% | +1.28% | +9.46% | +204.11% | +198.39% | - | 5.55B | |
| -3.79% | -8.90% | -7.97% | -20.70% | -37.34% | -51.62% | -42.42% | -71.61% | - | 5.3B | |
| Average | -0.72% | -2.42% | +16.99% | +30.98% | +46.77% | +71.23% | +144.90% | +126.48% | +1,028.78% | 25.32B | |
| Weighted average by Cap. | -0.86% | -1.51% | +30.29% | +47.70% | +59.66% | +88.45% | +85.99% | +58.51% | +520.00% |
- Stock Market
- Stocks
- BIIB Stock
- Sector Biogen Inc.
Select your edition
All financial news and data tailored to specific country editions
